首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1738162

分子生物學酵素、套件和試劑市場（2025-2029）

Global Molecular Biology Enzymes, Kits, and Reagents Market 2025-2029

出版日期: 2025年05月21日 | 出版商:

TechNavio | 英文 232 Pages | 訂單完成後即時交付

價格

簡介目錄圖表

分子生物學酵素、套件和試劑市場預計在 2024-2029 年期間達到 105.609 億美元，預測期內的複合年成長率為 9.5%。

本報告對分子生物學酵素、套件和試劑市場進行了全面的分析，包括市場規模、預測、趨勢、成長動力、挑戰以及涵蓋約 25 家供應商的供應商分析。

該報告提供了當前市場狀況、最新趨勢和促進因素以及整體市場環境的最新分析。市場受到遺傳和慢性疾病盛行率上升、資金籌措以及個人化醫療成長等因素的驅動。

市場覆蓋
基準年	2025
年底	2029
預測期	2025-2029
成長動力	加速度
與前一年同期比較	8.8%
複合年成長率	9.5%
增量金額	105.609億美元

本研究客觀地結合了一手和二手訊息，並納入了行業主要參與者的回饋。報告包含全面的市場規模數據、按區域細分的分析、供應商格局以及對主要企業的分析。報告同時包含歷史數據和預測數據。

研究指出，自動化與高通量技術的整合是未來幾年推動分子生物學酵素、套件和試劑市場成長的主要原因之一。此外，次世代定序的擴展和企業併購的增加也將帶來巨大的市場需求。

地理細分
區域比較
北美：2024-2029 年市場規模及預測
歐洲：2024-2029 年市場規模及預測
亞洲：2024-2029 年市場規模及預測
世界其他地區：2024-2029 年市場規模及預測
美國：市場規模及預測（2024-2029）
中國：2024-2029年市場規模及預測
德國：2024-2029年市場規模及預測
印度：2024-2029 年市場規模及預測
英國：2024-2029 年市場規模及預測
加拿大：2024-2029 年市場規模及預測
法國：2024-2029年市場規模及預測
日本：2024-2029 年市場規模及預測
巴西：2024-2029 年市場規模及預測
韓國：2024-2029 年市場規模及預測
按地區分類的市場機會

第13章促進因素、挑戰、機會與限制因素

市場促進因素
市場挑戰
促進因素和挑戰的影響
市場機會與限制

第14章競爭格局

概述
競爭格局
令人困惑的情況
產業風險

第15章競爭分析

公司簡介
企業排名指數
公司市場定位
Agilent Technologies Inc.
Bio Rad Laboratories Inc.
Bio Techne Corp.
Danaher Corp.
F. Hoffmann La Roche Ltd.
Illumina Inc.
Intact Genomics Inc
LGC Science Group Holdings Ltd.
Lonza Group Ltd.
Merck KGaA
New England Biolabs Inc.
Promega Corp.
Sartorius AG
Takara Bio Inc.
Thermo Fisher Scientific Inc.

第16章附錄

簡介目錄圖表

Product Code: IRTNTR71334

The molecular biology enzymes, kits, and reagents market is forecasted to grow by USD 10,560.9 mn during 2024-2029, accelerating at a CAGR of 9.5% during the forecast period. The report on the molecular biology enzymes, kits, and reagents market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising prevalence of genetic and chronic diseases, increasing funding and investment, and growth of personalized medicine.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	8.8%
CAGR	9.5%
Incremental Value	$10,560.9 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's molecular biology enzymes, kits, and reagents market is segmented as below:

By Product

Kits and reagents
Enzymes

By Application

Sequencing
PCR
Epigenetic
Cloning
Others

By End-user

Biotech and pharma companies
Research and academic institutes
Hospitals and diagnostic centers

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the integration of automation and high-throughput technologies as one of the prime reasons driving the molecular biology enzymes, kits, and reagents market growth during the next few years. Also, expansion of next-generation sequencing and increasing number of mergers and acquisitions will lead to sizable demand in the market.

The report on the molecular biology enzymes, kits, and reagents market covers the following areas:

Molecular Biology Enzymes, Kits, And Reagents Market sizing
Molecular Biology Enzymes, Kits, And Reagents Market forecast
Molecular Biology Enzymes, Kits, And Reagents Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading molecular biology enzymes, kits, and reagents market vendors that include Agilent Technologies Inc., altona Diagnostics GmbH, Bio Rad Laboratories Inc., Bio Techne Corp., BioEcho Life Sciences GmbH, Cipla Inc., Danaher Corp., F. Hoffmann La Roche Ltd., Genes2Me Pvt. Ltd., HiMedia Laboratories, Illumina Inc., Intact Genomics Inc, LGC Science Group Holdings Ltd., Lonza Group Ltd., Merck KGaA, New England Biolabs Inc., Promega Corp., Sartorius AG, Takara Bio Inc., and Thermo Fisher Scientific Inc.. Also, the molecular biology enzymes, kits, and reagents market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Molecular Biology Enzymes, Kits, And Reagents Market 2019 - 2023
- Historic Market Size - Data Table on Global Molecular Biology Enzymes, Kits, And Reagents Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
- Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.4 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 Impact Analysis of U.S. Tariffs on Global Molecular Biology Enzymes, Kits, and Reagents Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product

8.1 Market segments
- Chart on Product - Market share 2024-2029 (%)
- Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
- Chart on Comparison by Product
- Data Table on Comparison by Product
8.3 Kits and reagents - Market size and forecast 2024-2029
- Chart on Kits and reagents - Market size and forecast 2024-2029 ($ million)
- Data Table on Kits and reagents - Market size and forecast 2024-2029 ($ million)
- Chart on Kits and reagents - Year-over-year growth 2024-2029 (%)
- Data Table on Kits and reagents - Year-over-year growth 2024-2029 (%)
8.4 Enzymes - Market size and forecast 2024-2029
- Chart on Enzymes - Market size and forecast 2024-2029 ($ million)
- Data Table on Enzymes - Market size and forecast 2024-2029 ($ million)
- Chart on Enzymes - Year-over-year growth 2024-2029 (%)
- Data Table on Enzymes - Year-over-year growth 2024-2029 (%)
8.5 Market opportunity by Product
- Market opportunity by Product ($ million)
- Data Table on Market opportunity by Product ($ million)

9 Market Segmentation by Application

9.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
9.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
9.3 Sequencing - Market size and forecast 2024-2029
- Chart on Sequencing - Market size and forecast 2024-2029 ($ million)
- Data Table on Sequencing - Market size and forecast 2024-2029 ($ million)
- Chart on Sequencing - Year-over-year growth 2024-2029 (%)
- Data Table on Sequencing - Year-over-year growth 2024-2029 (%)
9.4 PCR - Market size and forecast 2024-2029
- Chart on PCR - Market size and forecast 2024-2029 ($ million)
- Data Table on PCR - Market size and forecast 2024-2029 ($ million)
- Chart on PCR - Year-over-year growth 2024-2029 (%)
- Data Table on PCR - Year-over-year growth 2024-2029 (%)
9.5 Epigenetic - Market size and forecast 2024-2029
- Chart on Epigenetic - Market size and forecast 2024-2029 ($ million)
- Data Table on Epigenetic - Market size and forecast 2024-2029 ($ million)
- Chart on Epigenetic - Year-over-year growth 2024-2029 (%)
- Data Table on Epigenetic - Year-over-year growth 2024-2029 (%)
9.6 Cloning - Market size and forecast 2024-2029
- Chart on Cloning - Market size and forecast 2024-2029 ($ million)
- Data Table on Cloning - Market size and forecast 2024-2029 ($ million)
- Chart on Cloning - Year-over-year growth 2024-2029 (%)
- Data Table on Cloning - Year-over-year growth 2024-2029 (%)
9.7 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
9.8 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

10 Market Segmentation by End-user

10.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
10.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
10.3 Biotech and pharma companies - Market size and forecast 2024-2029
- Chart on Biotech and pharma companies - Market size and forecast 2024-2029 ($ million)
- Data Table on Biotech and pharma companies - Market size and forecast 2024-2029 ($ million)
- Chart on Biotech and pharma companies - Year-over-year growth 2024-2029 (%)
- Data Table on Biotech and pharma companies - Year-over-year growth 2024-2029 (%)
10.4 Research and academic institutes - Market size and forecast 2024-2029
- Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
- Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
- Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
- Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
10.5 Hospitals and diagnostic centers - Market size and forecast 2024-2029
- Chart on Hospitals and diagnostic centers - Market size and forecast 2024-2029 ($ million)
- Data Table on Hospitals and diagnostic centers - Market size and forecast 2024-2029 ($ million)
- Chart on Hospitals and diagnostic centers - Year-over-year growth 2024-2029 (%)
- Data Table on Hospitals and diagnostic centers - Year-over-year growth 2024-2029 (%)
10.6 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
15.5 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
15.6 Bio Techne Corp.
- Bio Techne Corp. - Overview
- Bio Techne Corp. - Business segments
- Bio Techne Corp. - Key news
- Bio Techne Corp. - Key offerings
- Bio Techne Corp. - Segment focus
- SWOT
15.7 Danaher Corp.
- Danaher Corp. - Overview
- Danaher Corp. - Business segments
- Danaher Corp. - Key news
- Danaher Corp. - Key offerings
- Danaher Corp. - Segment focus
- SWOT
15.8 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.9 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
15.10 Intact Genomics Inc
- Intact Genomics Inc - Overview
- Intact Genomics Inc - Product / Service
- Intact Genomics Inc - Key offerings
- SWOT
15.11 LGC Science Group Holdings Ltd.
- LGC Science Group Holdings Ltd. - Overview
- LGC Science Group Holdings Ltd. - Product / Service
- LGC Science Group Holdings Ltd. - Key offerings
- SWOT
15.12 Lonza Group Ltd.
- Lonza Group Ltd. - Overview
- Lonza Group Ltd. - Business segments
- Lonza Group Ltd. - Key news
- Lonza Group Ltd. - Key offerings
- Lonza Group Ltd. - Segment focus
- SWOT
15.13 Merck KGaA
- Merck KGaA - Overview
- Merck KGaA - Business segments
- Merck KGaA - Key news
- Merck KGaA - Key offerings
- Merck KGaA - Segment focus
- SWOT
15.14 New England Biolabs Inc.
- New England Biolabs Inc. - Overview
- New England Biolabs Inc. - Product / Service
- New England Biolabs Inc. - Key offerings
- SWOT
15.15 Promega Corp.
- Promega Corp. - Overview
- Promega Corp. - Product / Service
- Promega Corp. - Key offerings
- SWOT
15.16 Sartorius AG
- Sartorius AG - Overview
- Sartorius AG - Business segments
- Sartorius AG - Key news
- Sartorius AG - Key offerings
- Sartorius AG - Segment focus
- SWOT
15.17 Takara Bio Inc.
- Takara Bio Inc. - Overview
- Takara Bio Inc. - Product / Service
- Takara Bio Inc. - Key offerings
- SWOT
15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations

簡介目錄圖表

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Product
Exhibits6: Executive Summary - Chart on Market Segmentation by Application
Exhibits7: Executive Summary - Chart on Market Segmentation by End-user
Exhibits8: Executive Summary - Chart on Incremental Growth
Exhibits9: Executive Summary - Data Table on Incremental Growth
Exhibits10: Executive Summary - Chart on Company Market Positioning
Exhibits11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits12: Overview on criticality of inputs and factors of differentiation
Exhibits13: Overview on factors of disruption
Exhibits14: Impact of drivers and challenges in 2024 and 2029
Exhibits15: Parent Market
Exhibits16: Data Table on - Parent Market
Exhibits17: Market characteristics analysis
Exhibits18: Value chain analysis
Exhibits19: Offerings of companies included in the market definition
Exhibits20: Market segments
Exhibits21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits25: Historic Market Size - Data Table on Global Molecular Biology Enzymes, Kits, And Reagents Market 2019 - 2023 ($ million)
Exhibits26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits27: Historic Market Size - Application Segment 2019 - 2023 ($ million)
Exhibits28: Historic Market Size - End-user Segment 2019 - 2023 ($ million)
Exhibits29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits31: Five forces analysis - Comparison between 2024 and 2029
Exhibits32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits37: Chart on Market condition - Five forces 2024 and 2029
Exhibits38: Chart on Product - Market share 2024-2029 (%)
Exhibits39: Data Table on Product - Market share 2024-2029 (%)
Exhibits40: Chart on Comparison by Product
Exhibits41: Data Table on Comparison by Product
Exhibits42: Chart on Kits and reagents - Market size and forecast 2024-2029 ($ million)
Exhibits43: Data Table on Kits and reagents - Market size and forecast 2024-2029 ($ million)
Exhibits44: Chart on Kits and reagents - Year-over-year growth 2024-2029 (%)
Exhibits45: Data Table on Kits and reagents - Year-over-year growth 2024-2029 (%)
Exhibits46: Chart on Enzymes - Market size and forecast 2024-2029 ($ million)
Exhibits47: Data Table on Enzymes - Market size and forecast 2024-2029 ($ million)
Exhibits48: Chart on Enzymes - Year-over-year growth 2024-2029 (%)
Exhibits49: Data Table on Enzymes - Year-over-year growth 2024-2029 (%)
Exhibits50: Market opportunity by Product ($ million)
Exhibits51: Data Table on Market opportunity by Product ($ million)
Exhibits52: Chart on Application - Market share 2024-2029 (%)
Exhibits53: Data Table on Application - Market share 2024-2029 (%)
Exhibits54: Chart on Comparison by Application
Exhibits55: Data Table on Comparison by Application
Exhibits56: Chart on Sequencing - Market size and forecast 2024-2029 ($ million)
Exhibits57: Data Table on Sequencing - Market size and forecast 2024-2029 ($ million)
Exhibits58: Chart on Sequencing - Year-over-year growth 2024-2029 (%)
Exhibits59: Data Table on Sequencing - Year-over-year growth 2024-2029 (%)
Exhibits60: Chart on PCR - Market size and forecast 2024-2029 ($ million)
Exhibits61: Data Table on PCR - Market size and forecast 2024-2029 ($ million)
Exhibits62: Chart on PCR - Year-over-year growth 2024-2029 (%)
Exhibits63: Data Table on PCR - Year-over-year growth 2024-2029 (%)
Exhibits64: Chart on Epigenetic - Market size and forecast 2024-2029 ($ million)
Exhibits65: Data Table on Epigenetic - Market size and forecast 2024-2029 ($ million)
Exhibits66: Chart on Epigenetic - Year-over-year growth 2024-2029 (%)
Exhibits67: Data Table on Epigenetic - Year-over-year growth 2024-2029 (%)
Exhibits68: Chart on Cloning - Market size and forecast 2024-2029 ($ million)
Exhibits69: Data Table on Cloning - Market size and forecast 2024-2029 ($ million)
Exhibits70: Chart on Cloning - Year-over-year growth 2024-2029 (%)
Exhibits71: Data Table on Cloning - Year-over-year growth 2024-2029 (%)
Exhibits72: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits73: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits74: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits75: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits76: Market opportunity by Application ($ million)
Exhibits77: Data Table on Market opportunity by Application ($ million)
Exhibits78: Chart on End-user - Market share 2024-2029 (%)
Exhibits79: Data Table on End-user - Market share 2024-2029 (%)
Exhibits80: Chart on Comparison by End-user
Exhibits81: Data Table on Comparison by End-user
Exhibits82: Chart on Biotech and pharma companies - Market size and forecast 2024-2029 ($ million)
Exhibits83: Data Table on Biotech and pharma companies - Market size and forecast 2024-2029 ($ million)
Exhibits84: Chart on Biotech and pharma companies - Year-over-year growth 2024-2029 (%)
Exhibits85: Data Table on Biotech and pharma companies - Year-over-year growth 2024-2029 (%)
Exhibits86: Chart on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Exhibits87: Data Table on Research and academic institutes - Market size and forecast 2024-2029 ($ million)
Exhibits88: Chart on Research and academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits89: Data Table on Research and academic institutes - Year-over-year growth 2024-2029 (%)
Exhibits90: Chart on Hospitals and diagnostic centers - Market size and forecast 2024-2029 ($ million)
Exhibits91: Data Table on Hospitals and diagnostic centers - Market size and forecast 2024-2029 ($ million)
Exhibits92: Chart on Hospitals and diagnostic centers - Year-over-year growth 2024-2029 (%)
Exhibits93: Data Table on Hospitals and diagnostic centers - Year-over-year growth 2024-2029 (%)
Exhibits94: Market opportunity by End-user ($ million)
Exhibits95: Data Table on Market opportunity by End-user ($ million)
Exhibits96: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits97: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits98: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits99: Chart on Geographic comparison
Exhibits100: Data Table on Geographic comparison
Exhibits101: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits102: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits103: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits104: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits105: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits106: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits107: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits108: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits109: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits110: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits111: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits112: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits113: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits114: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits115: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits116: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits117: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits118: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits119: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits120: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits121: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits122: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits123: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits124: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits125: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits126: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits127: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits128: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits129: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits130: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits131: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits132: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits133: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits134: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits135: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits136: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits137: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits138: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits139: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits140: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits141: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits142: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits143: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits144: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits145: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits146: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits147: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits148: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits149: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits150: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits151: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits152: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits153: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits154: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits155: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits156: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits157: Market opportunity By Geographical Landscape ($ million)
Exhibits158: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits159: Impact of drivers and challenges in 2024 and 2029
Exhibits160: Overview on criticality of inputs and factors of differentiation
Exhibits161: Overview on factors of disruption
Exhibits162: Impact of key risks on business
Exhibits163: Companies covered
Exhibits164: Company ranking index
Exhibits165: Matrix on companies position and classification
Exhibits166: Agilent Technologies Inc. - Overview
Exhibits167: Agilent Technologies Inc. - Business segments
Exhibits168: Agilent Technologies Inc. - Key news
Exhibits169: Agilent Technologies Inc. - Key offerings
Exhibits170: Agilent Technologies Inc. - Segment focus
Exhibits171: SWOT
Exhibits172: Bio Rad Laboratories Inc. - Overview
Exhibits173: Bio Rad Laboratories Inc. - Business segments
Exhibits174: Bio Rad Laboratories Inc. - Key news
Exhibits175: Bio Rad Laboratories Inc. - Key offerings
Exhibits176: Bio Rad Laboratories Inc. - Segment focus
Exhibits177: SWOT
Exhibits178: Bio Techne Corp. - Overview
Exhibits179: Bio Techne Corp. - Business segments
Exhibits180: Bio Techne Corp. - Key news
Exhibits181: Bio Techne Corp. - Key offerings
Exhibits182: Bio Techne Corp. - Segment focus
Exhibits183: SWOT
Exhibits184: Danaher Corp. - Overview
Exhibits185: Danaher Corp. - Business segments
Exhibits186: Danaher Corp. - Key news
Exhibits187: Danaher Corp. - Key offerings
Exhibits188: Danaher Corp. - Segment focus
Exhibits189: SWOT
Exhibits190: F. Hoffmann La Roche Ltd. - Overview
Exhibits191: F. Hoffmann La Roche Ltd. - Business segments
Exhibits192: F. Hoffmann La Roche Ltd. - Key news
Exhibits193: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits194: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits195: SWOT
Exhibits196: Illumina Inc. - Overview
Exhibits197: Illumina Inc. - Business segments
Exhibits198: Illumina Inc. - Key news
Exhibits199: Illumina Inc. - Key offerings
Exhibits200: Illumina Inc. - Segment focus
Exhibits201: SWOT
Exhibits202: Intact Genomics Inc - Overview
Exhibits203: Intact Genomics Inc - Product / Service
Exhibits204: Intact Genomics Inc - Key offerings
Exhibits205: SWOT
Exhibits206: LGC Science Group Holdings Ltd. - Overview
Exhibits207: LGC Science Group Holdings Ltd. - Product / Service
Exhibits208: LGC Science Group Holdings Ltd. - Key offerings
Exhibits209: SWOT
Exhibits210: Lonza Group Ltd. - Overview
Exhibits211: Lonza Group Ltd. - Business segments
Exhibits212: Lonza Group Ltd. - Key news
Exhibits213: Lonza Group Ltd. - Key offerings
Exhibits214: Lonza Group Ltd. - Segment focus
Exhibits215: SWOT
Exhibits216: Merck KGaA - Overview
Exhibits217: Merck KGaA - Business segments
Exhibits218: Merck KGaA - Key news
Exhibits219: Merck KGaA - Key offerings
Exhibits220: Merck KGaA - Segment focus
Exhibits221: SWOT
Exhibits222: New England Biolabs Inc. - Overview
Exhibits223: New England Biolabs Inc. - Product / Service
Exhibits224: New England Biolabs Inc. - Key offerings
Exhibits225: SWOT
Exhibits226: Promega Corp. - Overview
Exhibits227: Promega Corp. - Product / Service
Exhibits228: Promega Corp. - Key offerings
Exhibits229: SWOT
Exhibits230: Sartorius AG - Overview
Exhibits231: Sartorius AG - Business segments
Exhibits232: Sartorius AG - Key news
Exhibits233: Sartorius AG - Key offerings
Exhibits234: Sartorius AG - Segment focus
Exhibits235: SWOT
Exhibits236: Takara Bio Inc. - Overview
Exhibits237: Takara Bio Inc. - Product / Service
Exhibits238: Takara Bio Inc. - Key offerings
Exhibits239: SWOT
Exhibits240: Thermo Fisher Scientific Inc. - Overview
Exhibits241: Thermo Fisher Scientific Inc. - Business segments
Exhibits242: Thermo Fisher Scientific Inc. - Key news
Exhibits243: Thermo Fisher Scientific Inc. - Key offerings
Exhibits244: Thermo Fisher Scientific Inc. - Segment focus
Exhibits245: SWOT
Exhibits246: Inclusions checklist
Exhibits247: Exclusions checklist
Exhibits248: Currency conversion rates for US$
Exhibits249: Research methodology
Exhibits250: Information sources
Exhibits251: Data validation
Exhibits252: Validation techniques employed for market sizing
Exhibits253: Data synthesis
Exhibits254: 360 degree market analysis
Exhibits255: List of abbreviations

02-2729-4219

+886-2-2729-4219

License/價格

相關商品

2025 年全球分子生物學酵素、套件和試劑市場報告

分子生物學酶、套件和試劑市場：按類型、應用和最終用戶分類 - 全球預測 2025-2030

溴化乙錠市場：按類型、應用分類 - 2025-2030 年全球預測

2024 年至 2031 年分子生物學酵素、試劑盒和試劑市場（按產品、應用、最終用戶和地區劃分）

到 2030 年分子生物酶市場預測：按產品、應用、最終用戶和地區分類的全球分析

FAQ

分子生物學酵素、套件和試劑市場（2025-2029）

Global Molecular Biology Enzymes, Kits, and Reagents Market 2025-2029

目錄

第1章執行摘要

第2章 Technavio 分析

第3章市場狀況

第4章市場規模

第5章市場規模表現

第6章定性分析

第7章五力分析

8.按產品細分市場

第9章按應用分類的市場細分

第10章依最終用戶細分市場

第11章客戶情況

第12章地區情勢